5 Heart Attack Clinical Trials in Fullerton, CA (2026)

Q: How do I join a clinical trial in Fullerton?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you.

Recruiting Heart Attack Studies in Fullerton

NCT04638647Recruiting

Secukinumab Open Label Roll-over Extension Protocol

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment w...

Fullerton, CAPHASE41,000 participantsNovartis Pharmaceuticals

View Study Details

NCT06625060Recruiting

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and s...

Fullerton, CAPHASE2641 participantsIpsen

View Study Details

NCT07438496Recruiting

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

The purpose of this study is to evaluate how well nipocalimab works as compared to placebo in participants with moderate to severe Systemic lupus erythematosus (SLE, a long-term disease where the immu...

Fullerton, CAPHASE3600 participantsJanssen Research & Development, LLC

View Study Details

NCT06411249Recruiting

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ...

Fullerton, CAPHASE4350 participantsGlaxoSmithKline

View Study Details

NCT06308978Recruiting

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants ...

Fullerton, CAPHASE1244 participantsFate Therapeutics

View Study Details

About Heart Attack Clinical Trials in Fullerton

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 5 heart attack clinical trials recruiting participants in Fullerton, CA. These studies are seeking a combined 2,835 participants. Research is being sponsored by Novartis Pharmaceuticals, Ipsen, Janssen Research & Development, LLC and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Fullerton — FAQ

Are there heart attack clinical trials in Fullerton?

Yes, there are 5 heart attack clinical trials currently recruiting in Fullerton, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fullerton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.

Are clinical trials in Fullerton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 5 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 17, 2026 from ClinicalTrials.gov